HYDERABAD, OCTOBER 03, 2024: The Drug Control Administration, Telangana has detected several substandard drugs circulating in the Telangana State.
DCA adopted a risk-based sampling approach. DCA issued directions to all field officers, i.e., Drug Inspectors, outlining the risk indicators to be considered for collecting samples from the supply chain and manufacturing facilities, which significantly increased the detection of substandard drugs circulating in the market.
Drugs Control Laboratory, Hyderabad reported 93 Not of Standard Quality (substandard) drugs from January to August 2024. In September-2024, the Drug Control Laboratory reported 14 Not of Standard Quality (substandard) drugs.
The drugs declared as Not of Standard Quality in Sptember included antibiotics, antiulcer drugs, anti-allergics, haematinics, etc. The samples failed in the tests for assay, dissolution, and description, which may render the medicines ineffective in treating diseases.
The details of the drugs declared as Not of Standard Quality (NSQ) or substandard by the Drug Control Laboratory in Hyderabad in September-2024 are listed as follows: Pantlar tablets, Parasyp 250 suspension, Ferrvis XT, Dixim O Dry syrup, Pepsai syrups, Cefixime tablets, Cefx O 200 tablets, Cefxi 200 tablets, Pozo 40 tablets, Nimpan 40 tablets, Zinfe SR capsules, Rovipod 100 tablets, Vertin 8 mg tablets, Trizene tablets,
The public may report any suspected manufacturing activity related to drugs, including narcotic drugs and psychotropic substances, in residential, commercial, or industrial areas, as well as any other complaints regarding illegal activities concerning medicines, through the Drugs Control Administration, Telangana Toll-Free Number 1800-599-6969, which is operational from 10:30 am to 5:00 pm on all working days.
About the Author
